"Expert, compassionate, team care for cancer patients and families. You will be supported by a team of physicians with specially trained oncology nurses, patient care navigators, social workers, dietitians, physical therapists, a genetic counselor, and a naturopathic physician working together to provide you the best cancer care.This multi-disciplinary approach allows us to care for your individual needs every step of the way. Cancer and infusion services are also available at Billings Clinic Cody. The providers at Billings Clinic follow evidence-based guidelines established by the National Comprehensive Cancer Network (NCCN)."

During the past decade, Billings Clinic Cancer Center conducted 205 clinical trials. In the 10-year time frame, 205 clinical trials started and 150 clinical trials were completed, i.e. on average, 73.2% percent of trials that started reached the finish line to date. In the past 5 years, 79 clinical trials started and 93 clinical trials were completed. i.e. 117.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Billings Clinic Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 164 trials, followed by "SWOG Cancer Research Network" with 64 trials sponsored, "Alliance for Clinical Trials in Oncology" with 56 trials sponsored, "NRG Oncology" with 23 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 23 trials sponsored. Other sponsors include 38 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Billings Clinic Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 189 trials as a collaborator, "NRG Oncology" with 41 trials as a collaborator, "Canadian Cancer Trials Group" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 9 trials as a collaborator and "Eastern Cooperative Oncology Group" with 8 trials as a collaborator. Other collaborators include 74 different institutions and companies that were collaborators in the rest 55 trials.

According to Clinical.Site data, the most researched conditions in "Billings Clinic Cancer Center" are "Breast Cancer" (15 trials), "Recurrent Ovarian Carcinoma" (11 trials), "Invasive Breast Carcinoma" (10 trials), "Recurrent Breast Carcinoma" (10 trials) and "Recurrent Squamous Cell Lung Carcinoma" (10 trials). Many other conditions were trialed in "Billings Clinic Cancer Center" in a lesser frequency.

Most popular intervention types in "Billings Clinic Cancer Center" are "Drug" (294 trials), "Other" (214 trials), "Biological" (142 trials), "Procedure" (86 trials) and "Radiation" (71 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (116 trials), "Quality-of-Life Assessment" (88 trials), "Questionnaire Administration" (51 trials), "Paclitaxel" (47 trials) and "Carboplatin" (45 trials). Other intervention names were less common.

The vast majority of trials in "Billings Clinic Cancer Center" are 276 trials for "All" genders, 73 trials for "Female" genders and 18 trials for "Male" genders.

Currently, there are NaN active trials in "Billings Clinic Cancer Center". undefined are not yet recruiting, 78 are recruiting, 151 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 105 completed trials in Billings Clinic Cancer Center, 6 suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in Billings Clinic Cancer Center, 17 "Phase 1" clinical trials were conducted, 184 "Phase 2" clinical trials and 180 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 11 trials that are defined as “Not Applicable".